Oklahoma Board of Pharmacy takes action against pharmacist for a number of issues, including compounding a drug product that is commercially available in the marketplace; compounding preparations to be given or sold for resale by prescribers or other persons; failing to prepare and review all compounding records to ensure that no errors have occurred in the compounding process; failing to have written procedures for the compounding of drug preparations; failing to document a listing of the components, the order of component mixing, and a description of the compounding process; failing to label any excess compounded preparation; failing to follow written procedures in the execution of the compounding procedure; failing to accurately weigh, measure, and subdivide, as appropriate, components; failing to retain any procedures or other records required to comply with USP compounding standards

Michael Brent Moore, DPh #10778 – Case No. 1373: Neither admits nor denies guilt on 300 counts including failing to establish and maintain effective controls against the diversion of prescription drugs; failing to oppose any secret arrangement between pharmacist and physician whereby fees are divided; filling a CDS prescription that did not contain the name, address, and DEA number of the practitioner, the date of delivery of the prescription, the name, dosage, and strength per dosage unit, the name and address of the patient, the directions for use and, if allowable, the number of refills; filling a written prescription for a Schedule III, IV, or V drug transmitted by facsimile that was not signed by the prescribing practitioner; filling a written prescription that was not signed by the practitioner; failing, as pharmacy manager, to be responsible for all aspects of the operation related to the practice of pharmacy; filling or refilling a prescription without authorization; compounding a drug product that is commercially available in the marketplace; compounding preparations to be given or sold for resale by prescribers or other persons; failing to prepare and review all compounding records to ensure that no errors have occurred in the compounding process; failing to have written procedures for the compounding of drug preparations; failing to document a listing of the components, the order of component mixing, and a description of the compounding process; failing to label any excess compounded preparation; failing to follow written procedures in the execution of the compounding procedure; failing to accurately weigh, measure, and subdivide, as appropriate, components; failing to retain any procedures or other records required to comply with USP compounding standards; and failing to ensure that all tasks performed by pharmacy technicians are performed under the immediate and direct supervision of a pharmacist. Suspended for 100 days until April 29, 2016. Probation for 10 years from April 30, 2016, to April 29, 2026. $105,000 fine. May not work as PIC during probation. Shall attend a one-day (eight-hour) law seminar in addition to the required 15 hours of CE during the calendar years of 2016, 2017, and 2018. All 15 hours of required CE that respondent must have to renew his license shall be live during the years 2016, 2017, and 2018.

source Oklahoma Board of Pharmacy April 2016 Newsletter